Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation.
Saved in:
| Title: | Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation. |
|---|---|
| Authors: | Li, Duo1 (AUTHOR), Zhong, Qi1 (AUTHOR), Xiao, Di1 (AUTHOR), Wang, Weifan1 (AUTHOR), Xie, Lejing1 (AUTHOR), Peng, Mei1 (AUTHOR), Xu, Cangcang1 (AUTHOR), Wu, Huaying1 (AUTHOR), Li, Zhuan1 (AUTHOR) zhuanli@hunnu.edu.cn, Yang, Xiaoping1 (AUTHOR) xiaoping.yang@hunnu.edu.cn |
| Source: | Cancer Cell International. 10/17/2025, Vol. 25 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 188778020 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Li%2C+Duo%22">Li, Duo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhong%2C+Qi%22">Zhong, Qi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xiao%2C+Di%22">Xiao, Di</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Weifan%22">Wang, Weifan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+Lejing%22">Xie, Lejing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peng%2C+Mei%22">Peng, Mei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Cangcang%22">Xu, Cangcang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Huaying%22">Wu, Huaying</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Zhuan%22">Li, Zhuan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> zhuanli@hunnu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Yang%2C+Xiaoping%22">Yang, Xiaoping</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> xiaoping.yang@hunnu.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Cell+International%22">Cancer Cell International</searchLink>. 10/17/2025, Vol. 25 Issue 1, p1-18. 18p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188778020 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12935-025-04012-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 18 StartPage: 1 Titles: – TitleFull: Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li, Duo – PersonEntity: Name: NameFull: Zhong, Qi – PersonEntity: Name: NameFull: Xiao, Di – PersonEntity: Name: NameFull: Wang, Weifan – PersonEntity: Name: NameFull: Xie, Lejing – PersonEntity: Name: NameFull: Peng, Mei – PersonEntity: Name: NameFull: Xu, Cangcang – PersonEntity: Name: NameFull: Wu, Huaying – PersonEntity: Name: NameFull: Li, Zhuan – PersonEntity: Name: NameFull: Yang, Xiaoping IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 10 Text: 10/17/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 14752867 Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: Cancer Cell International Type: main |
| ResultId | 1 |